Table 1 Comparison of baseline characteristics between non-ICU and ICU groups
From: Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19
Characteristic | Total (n = 214) | Non-ICU group (n = 161) | ICU group (n = 53) | P value |
|---|---|---|---|---|
Sociodemographic | Â | Â | Â | Â |
Age, median (IQR), years | 49.00 (39.00–56.00) | 46.00 (37.50–54.00) | 57.00 (50.50–75.50) |  < 0.001 |
Male/female, n (%) | 117 (54.7)/97 (45.3) | 88 (54.7)/73 (45.3) | 29 (54.7)/24 (45.3) | 0.994 |
Chronic medical diseases | Â | Â | Â | Â |
Hypertension, n (%) | 16 (7.5) | 11 (6.8) | 5 (9.4) | 0.746 |
Coronary heart disease, n (%) | 7 (3.3) | 3 (1.9) | 4 (7.5) | 0.116 |
Underlying pulmonary diseases, n (%) | 10 (4.7) | 4 (2.5) | 6 (11.3) | 0.023 |
Chronic liver or kidney disease, n (%) | 5 (2.3) | 3 (1.9) | 2 (3.8) | 0.599 |
Diabetes mellitus, n (%) | 24 (11.2) | 8 (5.0) | 16 (30.2) |  < 0.001 |
Malignancy, n (%) | 2 (0.9) | 0 (0.0) | 2 (3.8) | 0.060 |
Signs and symptoms on hospital admission | Â | Â | Â | Â |
Fever, n (%) | 112 (52.3) | 79 (49.1) | 33 (62.3) | 0.095 |
Chills, n (%) | 28 (13.1) | 19 (11.8) | 9 (17.0) | 0.332 |
Myalgia, n (%) | 26 (12.1) | 17 (10.6) | 9 (17.0) | 0.215 |
Fatigue, n (%) | 49 (22.9) | 29 (18.0) | 20 (37.7) | 0.003 |
Cough, n (%) | 137 (64.0) | 95 (59.0) | 42 (79.2) | 0.008 |
Expectoration, n (%) | 60 (28.0) | 39 (24.2) | 21 (39.6) | 0.030 |
Short of breath, n (%) | 41 (19.2) | 20 (12.4) | 21 (39.6) |  < 0.001 |
Chest tightness, n (%) | 19 (8.9) | 11 (6.8) | 8 (15.1) | 0.120 |
Chest pain, n (%) | 6 (2.8) | 2 (1.2) | 4 (7.5) | 0.034 |
Anorexia, n (%) | 27 (12.6) | 18 (11.2) | 9 (17.0) | 0.270 |
Nausea or vomiting, n (%) | 9 (4.2) | 6 (3.7) | 3 (5.7) | 0.831 |
Abdominal pain, n (%) | 4 (1.9) | 2 (1.2) | 2 (3.8) | 0.257 |
Diarrhea, n (%) | 13 (6.1) | 10 (6.2) | 3 (5.7) | 1.000 |
Headache, n (%) | 21 (9.8) | 15 (9.3) | 6 (11.3) | 0.671 |
Dizziness, n (%) | 21 (9.8) | 14 (8.7) | 7 (13.2) | 0.338 |
Others | Â | Â | Â | Â |
Onset of symptom to hospital admission, median (IQR), days | 6.00 (3.00–10.00) | 6.00 (3.00–10.00) | 7.00 (4.50–8.00) | 0.612 |
NCT of SARC-CoV-2, median (IQR), days | 17.00 (13.00–23.00) | 17.00 (13.00–23.00) | 21.00 (15.50–26.50) | 0.004 |
Length of hospital stay, median (IQR), days | 14.00 (12.00–22.00) | 13.00 (11.00–17.00) | 24.00 (14.50–37.00) |  < 0.001 |
Onset of symptom to hospital discharge or death, median (IQR), days | 22.00 (18.00–29.00) | 22.00 (18.00–29.00) | 30.00 (22.50–43.50) |  < 0.001 |